Open Government Portal
Open Data Search has recently undergone significant changes. The search page has moved to search.open.canada.ca/opendata. Please update existing bookmarks accordingly.
Found 10 records similar to Standing Committee on Health (HESA) - COVID-19 – Vaccines Rollout
The World Health Organization (WHO) refers to symptoms lasting for weeks or months after a COVID-19 infection as post COVID-19 condition. Some studies have reported later symptoms in patients with a severe COVID-19 infection. For example, those who were hospitalized or needed intensive care during recovery. However, post COVID-19 condition may also occur for people with mild or asymptomatic infection who were asked to isolate at home during the infectious phase.
People infected with COVID-19 can shed the virus through their stool, even if they don't have any symptoms. Testing a community's sewage (wastewater) can tell us if COVID-19 is increasing or decreasing in that community. Our scientists have developed a pan-Canadian wastewater network to monitor the spread of COVID-19 in Canada. This is in collaboration with provincial, territorial and municipal governments and academia across Canada.
When people still show symptoms of COVID-19 for weeks or months after their initial recovery, it’s called post COVID-19 condition. It’s also known as long COVID. Post COVID-19 condition may occur in some people after infection.
Pregnancy increases the risk of severe illness from COVID-19. The National Advisory Committee on Immunization (NACI) recommends you get a complete series with an mRNA COVID-19 vaccine if you're pregnant or breastfeeding. Getting the COVID-19 vaccine can prevent serious illness, hospitalization and complications.
COVID-19 is an illness caused by a coronavirus. Human coronaviruses are common and are typically associated with mild illnesses, similar to the common cold.
Several different types of treatments for COVID-19 have been developed. Examples include drugs that reduce or stop the virus from multiplying in human cells and drugs that treat the symptoms of COVID-19.
Canada’s research community is contributing to both the global and domestic response to
COVID-19 and is well-poised for significant discoveries.
This document provides guidance to health authorities working to protect people in Canada from extreme heat by considering COVID-19 in heat alert and response planning. COVID-19 information evolves rapidly and this document is based on the medical community's current understanding of this issue.
The importance of research and the Canadian Institutes
of Health Research (CIHR)’s pivotal role in Canada’s
response to COVID-19.